Elucidating molecular mechanisms and understanding genetic heterogeneity in drug discovery and complex biology can be achieved through high-throughput gene expression analysis and pathway assignment. Recent advances in RNA-seq methodologies have enabled accurate gene expression profiling from low-input and low-quality RNA samples, but analyzing hundreds or thousands of samples is an arduous exercise in library prep. QIAGEN’s QIAseq 3’ UPX technology provides a high-throughput RNA-seq library prep methodology where reverse transcription may be performed directly on lysed cells, while simultaneously assigning a unique ‘molecular index’ and ‘cell index’ to all cDNA synthesized from a sample. All subsequent full transcriptome or targeted panel library steps that follow occur in a single pooled tube. This technique allows ultra-plexing of thousands of samples per sequencing lane for a smart and resource-efficient workflow that enables the identification and characterization of gene signatures. 
About the speaker
Sujash Chatterjee, Ph.D., Senior Field Application Specialist, Genomics
QIAGEN
Date of recording:Wednesday, December 9, 2020
Duration:1 hour
Categories
Webinar
Academic Basic Research
Next Generation Sequencing
Sequencing
Molecular Biology
X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm